Prolaris

BEHAVIORAL2 trials

Sponsors

Myriad Genetic Laboratories, Inc., University of Michigan Rogel Cancer Center

Conditions

Prostate Cancer

Unknown Phase

Prospective Prolaris Value and Efficacy

TerminatedNCT03152448

Myriad Genetic Laboratories, Inc.Prostate Cancer

Start: 2015-09-01End: 2022-03-21Updated: 2022-06-13

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

Active, not recruitingNCT04396808

University of Michigan Rogel Cancer CenterProstate Cancer

Start: 2020-11-05End: 2031-03-01Updated: 2026-09-09

Related Papers

Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative.

2021-07-2024 citations